IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 178 filers reported holding IMPAX LABORATORIES INC in Q4 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $683,000 | +239.8% | 695,000 | +16077.8% | 0.02% | +162.5% |
Q1 2015 | $201,000 | -34.3% | 4,296 | -55.5% | 0.01% | -42.9% |
Q4 2014 | $306,000 | -30.6% | 9,654 | -48.1% | 0.01% | -22.2% |
Q3 2014 | $441,000 | -5.6% | 18,593 | +19.3% | 0.02% | -5.3% |
Q2 2014 | $467,000 | – | 15,580 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |